Patheon Inc. says it will sell three Canadian drug manufacturing and packaging facilities, but expects no job losses. To boost a falling profit margin, the company will sell its locations in Fort ...

Patheon Inc. has sold its Fort Erie and Burlington commercial manufacturing business to Pharmetics Inc. in a deal worth more than $5.75 million. The 250 manufacturing employees won’t lose their jobs ...

Removing the impact of income taxes, Patheon's third-quarter loss would have increased to $3.2-million from $1-million. Revenue for the contract drug maker rose to $172.7-million from $163.3-million.

Patheon Inc (TSX:PTI), a provider of drug development and manufacturing services, has agreed to be taken private in a deal that values the company at around US$1.4 billion. The buyers are U.S ...

Pharmaceutical supplier Patheon Inc. says it may be able to go ahead with a takeover bid from Swiss-based Lonza Group AG without the approval of major shareholder and hostile bidder JLL Partners Inc.

Patheon Inc. has completed the previously announced sale of its Fort Erie commercial manufacturing business to Pharmetics Inc. Pharmetics has acquired the assets, including equipment, facilities and ...

Patheon Inc.has agreed to acquire all the shares ofGlobal Pharm Inc.that it doesn't already own, for $9.5-million. Mississauga-based Patheon said it will finance the acquisition from retained ...

Drug manufacturer Patheon Inc. is moving its corporate head office from Mississauga to Research Triangle Park in North Carolina. The company said yesterday that “there will be no impact to ...

Drugmaker Patheon Corp., which touched a 52-week low last week on the TSX, is evaluating its "strategic and financial alternatives" and warns it expects lower earnings for the third quarter.

Patheon has announced that it has signed a strategic agreement with Grünenthal to serve as its preferred development partner for its products made using Grünenthal’s innovative abuse deterrent ...

What: Shares of Patheon (TSX: PTI) soared 62% today after Dutch health care company Royal DSM partnered up with hedge fund JLL Partners to take the contract drug maker private.

North Carolina-based Banner Pharmacaps was founded in 1994. The company's products, such as Soflet® Gelcaps and LiquiSoft™, are chewable liquid filled softgels that are used by major brands ...